GERON CORP (GERN) Form 10-K Annual Reports
GERON CORP (GERN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GERN
CIK: 886744
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerLara Kanjo
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-01 | 2026-09-30 | 4 Filing | 0001492256-26-000009 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000924 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000471 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-05 | 8-K | 0001193125-26-336508 | View SEC Doc Filr Page |
| S-8 | 2026-08-05 | — | S-8 | 0001193125-26-335509 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0000886744-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001492256-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-20 | 8-K | 0001193125-26-241842 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-20 | 4 Filing | 0001492256-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-20 | 4 Filing | 0001744662-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-20 | 4 Filing | 0001553389-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-20 | 4 Filing | 0001944633-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-20 | 4 Filing | 0001688712-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002027 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-08 | — | SCHEDULE 13G/A Filing | 0001213900-26-053989 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0000886744-26-000032 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2026-04-13 | 4 Filing | 0001748392-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-04-14 | 2026-04-13 | 3 Filing | 0001748392-26-000004 | View SEC Doc Filr Page |
| ARS | 2026-04-07 | 2025-12-31 | ARS | 0000886744-26-000026 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-07 | — | DEFA14A | 0000886744-26-000025 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-07 | 2026-05-20 | DEF 14A | 0000886744-26-000024 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-31 | 4 Filing | 0001492256-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-26 | — | SCHEDULE 13G/A Filing | 0000102909-26-001402 | View SEC Doc Filr Page |
| 4 | 2026-03-26 | 2026-03-25 | 4 Filing | 0002014509-26-000003 | View SEC Doc Filr Page |
| 3 | 2026-03-26 | 2026-03-25 | 3 Filing | 0002014509-26-000002 | View SEC Doc Filr Page |